The adverse influence of pretransplant interferon-alpha (IFN-alpha) on transplant outcome after marrow transplantation for chronic phrase chronic myelogenous leukemia increases with the duration of IFN-alpha exposure

MeSH terms

• Antineoplastic Agents / adverse effects*
• Antineoplastic Agents / therapeutic use
• Antiviral Agents / adverse effects*
• Antiviral Agents / therapeutic use
• Bone Marrow Transplantation / mortality*
• Graft Rejection
• Histocompatibility Testing
• Humans
• Interferon-alpha / adverse effects*
• Interferon-alpha / therapeutic use
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy*
• Survival Analysis
• Transplantation, Homologous